The company will use the funds to hasten product development, engineering and go-to-market efforts to meet market demand.

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as ...

Abridge, a generative AI platform for clinical conversations, has raised $300 million in Series E funding, bringing its valuation to a reported $5.3 billion. Andreessen Horowitz ( a16z) led the round ...

The GenAIus Challenge, launched in April 2024 by Singapore's national health tech agency, Synapxe, connected over 160 public healthcare staff – including doctors, nurses, and administrators – directly ...

The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.

Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the ...

Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.

Pharma giant Novo Nordisk announced that it is terminating its contract with direct-to-consumer virtual care company Hims & Hers, which was launched less than two months ago, due to concerns about ...

At-home testing company Visby Medical announced that it has received approximately $55 million in funding, with the potential to raise an additional $10 million.

Numerous Google Cloud services, including those used widely within healthcare, such as Google Vertex AI Online Prediction, Dialogflow CX, Agent Assist and Contact Center AI, were down for nearly four ...

Pharmacy benefits manager LucyRx is partnering with Personify Health, a health navigation and benefits company, to provide employers with a more individualized, clinically focused strategy for ...